A Community-Based Screening Program to Identify Participants at High Risk for Amyloid Pathology

A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

NCT05310071 ·Status: TERMINATED ·Phase: PHASE3

Clinical Evaluation of Blood-Based Assays for Rapid Detection of Aβ Pathology in Alzheimer's Disease

NCT06889896 ·Status: ENROLLING_BY_INVITATION

Evaluation of [123I] MNI-308 and SPECT as a Marker of Beta-amyloid Protein Deposition in AD Subjects Compared to HC

NCT00544453 ·Status: TERMINATED ·Phase: PHASE1

Blood Gene Expression Signature in Patients Diagnosed With Probable Alzheimer's Disease Compared to Patients Suffering From Other Types of Dementia

NCT00880347 ·Status: COMPLETED ·Phase: NA

Safety and Tolerability of AZD0530 (Saracatinib) in Alzheimer's Disease

NCT01864655 ·Status: COMPLETED ·Phase: PHASE1

Alzheimer's Disease Biomarkers in Cerebrospinal Fluid in Insulin-resistant Men

NCT02010476 ·Status: COMPLETED

A Study to Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease

NCT01397578 ·Status: COMPLETED ·Phase: PHASE2

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

NCT07177352 ·Status: RECRUITING ·Phase: PHASE3

Evaluation of [123I] AV151 and SPECT in Subjects w/ AD in Comparison to Healthy Subjects

NCT00605046 ·Status: TERMINATED ·Phase: PHASE1

Statin Effects on Beta-Amyloid and Cerebral Perfusion in Adults at Risk for Alzheimer's Disease

NCT00939822 ·Status: COMPLETED ·Phase: PHASE2

BioFINDER-Brown: Examination of Alzheimer's Disease Biomarkers

NCT05457998 ·Status: ENROLLING_BY_INVITATION

An Observational Study of Aducanumab-avwa in Participants With Alzheimer's Disease in the US

NCT05097131 ·Status: TERMINATED

Discovery of Novel Biomarkers That Will Lead to the Early Detection of Alzheimer's Disease

NCT03136679 ·Status: COMPLETED

A Multiple Ascending Dose Study in Healthy Volunteers and Patients With Alzheimer's Disease

NCT05804383 ·Status: COMPLETED ·Phase: PHASE1

Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease

NCT00955422 ·Status: COMPLETED

Longitudinal Early-onset Alzheimer's Disease Study Protocol

NCT03507257 ·Status: RECRUITING

CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease

NCT02021682 ·Status: COMPLETED

A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

NCT02565511 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Biomarker Effects of ALZ-801 in APOE4 Carriers With Early Alzheimer's Disease

NCT04693520 ·Status: COMPLETED ·Phase: PHASE2

A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)

NCT02951598 ·Status: ACTIVE_NOT_RECRUITING

Study of ASN51 in Adults With Early Alzheimer's Disease

NCT06677203 ·Status: TERMINATED ·Phase: PHASE2

COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE

NCT02860338 ·Status: COMPLETED

Evaluation of [123I] AV51 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

NCT00556660 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

NCT00605059 ·Status: TERMINATED ·Phase: PHASE1

A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

NCT04971733 ·Status: COMPLETED ·Phase: PHASE1/PHASE2